Literature DB >> 35292757

Editorial on "A systematic review of microbial markers for risk prediction of colorectal neoplasia" by Yu and coauthors.

Maikel P Peppelenbosch1, Vincent T Janmaat2.   

Abstract

Yu and colleagues show microbial markers are correlated with CRC and to a lesser degree with adenomas. Moreover, faecal microbial markers can be isolated from quantitative fecal immunochemical test cartridges and appear to improve results. If studies become less heterogeneous, it appears feasible to apply microbial markers in screening programmes.
© 2022. The Author(s), under exclusive licence to Springer Nature Limited.

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35292757      PMCID： PMC9043177          DOI： 10.1038/s41416-022-01774-x

Source DB:  PubMed          Journal:  Br J Cancer        ISSN： 0007-0920            Impact factor:   9.075


  6 in total

Review 1.  Ecological control of the gastrointestinal tract. The role of probiotic flora.

Authors:  S Bengmark
Journal:  Gut       Date:  1998-01       Impact factor: 23.059

Review 2.  Intestinal flora in health and disease.

Authors:  G L Simon; S L Gorbach
Journal:  Gastroenterology       Date:  1984-01       Impact factor: 22.682

3.  The microbial contribution to human faecal mass.

Authors:  A M Stephen; J H Cummings
Journal:  J Med Microbiol       Date:  1980-02       Impact factor: 2.472

4.  Cancer statistics, 2022.

Authors:  Rebecca L Siegel; Kimberly D Miller; Hannah E Fuchs; Ahmedin Jemal
Journal:  CA Cancer J Clin       Date:  2022-01-12       Impact factor: 508.702

5.  Microbiota-based model improves the sensitivity of fecal immunochemical test for detecting colonic lesions.

Authors:  Nielson T Baxter; Mack T Ruffin; Mary A M Rogers; Patrick D Schloss
Journal:  Genome Med       Date:  2016-04-06       Impact factor: 11.117

6.  A systematic review of microbial markers for risk prediction of colorectal neoplasia.

Authors:  Lili Yu; Gang Zhao; Lijuan Wang; Xuan Zhou; Jing Sun; Xinxuan Li; Yingshuang Zhu; Yazhou He; Kleovoulos Kofonikolas; Debby Bogaert; Malcolm Dunlop; Yimin Zhu; Evropi Theodoratou; Xue Li
Journal:  Br J Cancer       Date:  2022-03-15       Impact factor: 9.075
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.